Loading...
Insmed Incorporated
INSM•NASDAQ
Healthcare
Medical - Pharmaceuticals
$111.61
$0.37(0.33%)
Insmed Incorporated (INSM) Financial Performance & Income Statement Overview
Review Insmed Incorporated (INSM) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
19.17%
↑ 19.17%
Operating Income Growth
-23.76%
↓ 23.76%
Net Income Growth
-21.91%
↓ 21.91%
Operating Cash Flow Growth
-27.53%
↓ 27.53%
Operating Margin
-230.21%
↓ 230.21%
Gross Margin
76.16%
↑ 76.16%
Net Profit Margin
-265.93%
↓ 265.93%
ROE
-446.98%
↓ 446.98%
ROIC
-56.10%
↓ 56.10%
Insmed Incorporated (INSM) Income Statement & Financial Overview
Review Insmed Incorporated (INSM) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $403.25M | $555.03M | $461.45M | $1.25B |
| Short Term Investments | $796.20M | $878.80M | $1.006B | $0.00 |
| Cash & Short Term Investments | $1.20B | $1.43B | $1.47B | $1.25B |
| Net Receivables | $47.75M | $52.01M | $42.32M | $40.30M |
| Inventory | $100.71M | $98.58M | $98.47M | $90.06M |
| Other Current Assets | $54.78M | $37.24M | $41.15M | $41.02M |
| Total Current Assets | $1.40B | $1.62B | $1.65B | $1.42B |
| Property Plant & Equipment (Net) | $116.78M | $115.58M | $110.25M | $108.81M |
| Goodwill | $136.11M | $136.11M | $136.11M | $136.11M |
| Intangible Assets | $57.39M | $58.65M | $59.91M | $61.18M |
| Goodwill & Intangible Assets | $193.50M | $194.76M | $196.03M | $197.29M |
| Long Term Investments | $0.00 | $0.00 | $0.00 | $6.00M |
| Tax Assets | $0.00 | $0.00 | $0.00 | $30.31M |
| Other Non-Current Assets | $89.76M | $93.23M | $96.86M | $49.52M |
| Total Non-Current Assets | $400.04M | $403.57M | $403.13M | $391.93M |
| Total Assets | $1.80B | $2.03B | $2.05B | $1.81B |
| Account Payables | $57.68M | $73.03M | $64.95M | $51.36M |
| Short Term Debt | $6.56M | $24.64M | $24.73M | $233.31M |
| Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue | $0.00 | $0.00 | -$14.23M | $0.00 |
| Other Current Liabilities | $174.99M | $206.19M | $169.51M | $239.48M |
| Total Current Liabilities | $239.23M | $297.53M | $259.19M | $524.15M |
| Long Term Debt | $1.14B | $66.35M | $1.15B | $1.02B |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $327.53M | $1.38B | $160.96M | $225.82M |
| Total Non-Current Liabilities | $1.46B | $1.44B | $1.31B | $1.25B |
| Capital Lease Obligations | $38.30M | $45.49M | $45.04M | $37.25M |
| Total Liabilities | $1.70B | $1.74B | $1.57B | $1.77B |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $1.82M | $1.79M | $1.79M | $1.67M |
| Retained Earnings | -$4.62B | -$4.36B | -$4.12B | -$3.90B |
| Accumulated Other Comprehensive Income/Loss | -$902000.00 | -$2.29M | $547000.00 | -$2.83M |
| Total Stockholders Equity | $99.16M | $285.38M | $483.42M | $38.82M |
| Total Equity | $99.16M | $285.38M | $483.42M | $38.82M |
| Total Liabilities & Stockholders Equity | $1.80B | $2.03B | $2.05B | $1.81B |
| Total Investments | $796.20M | $878.80M | $1.006B | $6.00M |
| Total Debt | $1.14B | $45.49M | $999.87M | $1.38B |
| Net Debt | $740.13M | -$509.54M | $538.42M | $132.58M |
Insmed Incorporated (INSM) Balance Sheet Analysis
Insmed Incorporated (INSM) manages its money wisely, with plenty of -27.53% and -21.91% to cover its bills. The company’s long-term debts are manageable, balanced by steady -265.93%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a cautious position, giving it room to invest, expand, or adapt. For investors, this paints a risky picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan